<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03189654</url>
  </required_header>
  <id_info>
    <org_study_id>HDZNRW-KA_010_TB</org_study_id>
    <nct_id>NCT03189654</nct_id>
  </id_info>
  <brief_title>Noninvasive Ventilation Therapy for the Treatment of Pleural Effusion in Patients With Heart Failure</brief_title>
  <official_title>Noninvasive Ventilation Therapy for the Treatment of Pleural Effusion in Patients With Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heart and Diabetes Center North-Rhine Westfalia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ResMed GmbH &amp; Co KG</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Heart and Diabetes Center North-Rhine Westfalia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There are no investigations so far whether an application of positive pressure during
      non-invasive ventilation might be a therapeutic option for transudative pleural effusion in
      patients with heart failure. In view of the pathophysiological process with pleural effusion
      resulting from an increase in intravascular hydrostatic pressure, non-invasive ventilation
      might provide an improvement.

      The aim of the present study is to investigate whether an additional non-invasive ventilation
      therapy leads to an improved suppression of pleural effusion in heart failure patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2017</start_date>
  <completion_date type="Anticipated">March 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Days</target_duration>
  <primary_outcome>
    <measure>Amount of pleural effusion</measure>
    <time_frame>5 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>nt-Pro-BNP</measure>
    <time_frame>5 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac output</measure>
    <time_frame>5 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NYHA class</measure>
    <time_frame>5 days</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Pleural Effusion</condition>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Treatment group</arm_group_label>
    <description>Non-invasive ventilation after pleurocentesis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>Oxygen Administration via nasal tube</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Non-invasive ventilation</intervention_name>
    <description>Non-invasive Ventilation for a Minimum of 8 h per day after pleurocentesis</description>
    <arm_group_label>Treatment group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with decompensated heart failure and pleural effusion
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients admitted to our hospital on a routine or emergency basis

          -  Patients with heart failure according to the current ESC guidelines and chronic
             pleural effusion with clinical indication for pleurocentesis

          -  Non-invasively determined cardiac index of &lt; 2.5 l/min/m²

          -  BNP &gt; 300 pg/ml

          -  Transudative pleural effusion according to Light criteria

          -  Effective pleurocentesis with residual effusion on the side affected of &lt; 500 ml

          -  Tolerance of non-invasive ventilation without subjective or objective hemodynamic
             impairment as verified during a test ventilation

          -  No change in drug or other therapy for the duration of the study (5 days)

        Exclusion Criteria:

          -  Psychological or neurological concomitant disease making an informed consent
             impossible

          -  Pregnancy

          -  Pneumothorax or pneumomediastinum

          -  Pathologically low blood pressure, particularly associated with intravascular volume
             depletion

          -  Liquor discharge, recent head surgery or trauma

          -  Severe bullous lung disease

          -  Dehydration

          -  Current ventilation therapy

          -  Bilateral pleural effusion &gt; 500 ml at the time of enrolment

          -  Exudative pleural effusion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Bitter, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Heart and Diabetes Center North Rhine-Westphalia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marco Koester, MD</last_name>
    <phone>49 5731</phone>
    <phone_ext>973335</phone_ext>
    <email>mkoester@hdz-nrw.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Astrid Kleemeyer</last_name>
    <phone>49 5731</phone>
    <phone_ext>971258</phone_ext>
    <email>akleemeyer@hdz-nrw.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Clinic for Cardiology, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum</name>
      <address>
        <city>Bad Oeynhausen</city>
        <zip>32545</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Astrid Kleemeyer</last_name>
      <phone>49 5731 97</phone>
      <phone_ext>1258</phone_ext>
      <email>akleemeyer@hdz-nrw.de</email>
    </contact>
    <investigator>
      <last_name>Marco Köster, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 14, 2017</study_first_submitted>
  <study_first_submitted_qc>June 14, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 16, 2017</study_first_posted>
  <last_update_submitted>May 24, 2018</last_update_submitted>
  <last_update_submitted_qc>May 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Heart and Diabetes Center North-Rhine Westfalia</investigator_affiliation>
    <investigator_full_name>Thomas Bitter</investigator_full_name>
    <investigator_title>Senior physician</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Pleural Effusion</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

